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11β-hydroxysteroid dehydrogenase (11β-HSD) is an enzyme complex responsible 
for the conversion of hormonally active cortisol to inactive cortisone, and two isoforms 
of the enzyme (11β-HSD1 and 11β-HSD2) have been cloned and characterized. An 
immunohistochemical study was performed to determine the precise distribution of 
glucocorticoid receptors (GRs) and the isoforms of 11β-HSD in the rat (postnatal day 1, 
4, 10, and adult). Immunoreactivity of GRs was detected in the stria vascularis (SV), the 
outer hair cells (OHCs), the inner hair cells (IHCs), the spiral ligament (SLig), the spiral 
limbus (SLib), the spiral ganglion cells (SGCs), Reissner's membrane (RM), the 
cochlear nerve (CN), the vestibular hair cells (VHCs), the dark cells (DCs), and the 
vestibular nerve (VN) in the rats.  Immunostaining of 11β-HSD1 was observed in 
almost all the tissues in the cochlea and the vestibule except SLig, SLib, SGCs, CN, 
VHCs, and VN during all developmental stages, whereas, immunoreativity of 
11β-HSD2 was not detected in any of the inner ear tissues. A polymerase chain reaction 
(PCR) study was also performed on GRs, 11β-HSD1, and 11β-HSD2 in the OC, SV and 
vestibule of the postnatal rats, and revealed that mRNAs were detected in all those and 
tissues in all the developmental days of postnatal days 1, 4, and 10. This data indicates 
that expression of GRs and 11β-HSD isoforms in the inner ear is tissue and age-specific, 
and that different local steroid regulation by GRs and the isoforms of 11β-HSD is 
present in each part of the inner ear. 
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As glucocorticoids are widely used to treat various inner ear diseases, it is 
important to know their modes and/or sites of action in the inner ear.  Glucocorticoids 
are thought to regulate sensory transduction and homeostasis in the inner ear.  It has 
previously been demonstrated that glucocorticoid receptors (GRs) are present in the 
inner ear.  Nevertheless, there are still inconclusive issues to be addressed.   For 
instance, a study of GRs mRNA in adult rats showed it to be present in the spiral 
ligament (SLig) but not in the organ of Corti (OC) (Ten et al., 1993).  Regarding 
immunostaining of GRs in the OC of BALB/c mice, a study clearly indicated the 
presence of GRs (Hargunani et al., 2006) while others did not (Shimazaki et al., 2002).   
As glucocorticoids are suggested to regulate potassium ion recycling (Embark et al., 
2003; Lee and Marcus, 2002), GRs are assumed to play an essential role in the stria 
vascularis (SV).  A previous study regarding mRNA has not provided any further 
evidence of GRs in adult rats (Ten et al., 1993), and only a slight to weak 
immunostaining of GRs was observed in both postnatal developmental days and in 
adults (Zuo et al., 1995). 
GRs encoded by nuclear receptor subfamily 3, group C, member 1 (NR3C1) 
belong to the nuclear hormone receptor superfamily, and are expressed in the nucleus or 
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the cytoplasm of most cells (Niu et al., 2009).  However, in the inner ear, precise 
subcellular localization and polarity of GRs have not been shown yet even in animal 
inner ears.  Furthermore, little information on factors determining biological actions of 
glucocorticoids in animal inner ear is available.   
The concentration of gluococorticoids in the target cells is known to be regulated by 
11β-hydroxysteroid dehydrogenase (11β-HSD), an enzyme complex responsible for the 
conversion of hormonally active cortisol to inactive cortisone (Oppermann et al., 1997).  
Recently two isoforms of the enzyme (11β-HSD1 and 11β-HSD2) have been cloned and 
are known to be linked to human diseases such as insulin resistance, obesity, glaucoma, 
and hypertension (Oppermann et al., 1997; Seckl, 2004; Draper and Stewart, 2005).  
11β-HSD1 is found in a wide range of tissues such as the liver, adipose tissues, the 
choroid plexus of the brain, and the eyes. In contrast, 11β-HSD2 is mainly present in 
mineralocorticoid-selective target tissues such as the kidney, colon, pancreas, and 
placenta (Oppermann et al., 1997; Seckl, 2004; Draper and Stewart, 2005). 11β-HSD is 
known to be partly present in the inner ear (Ten et al., 1994), whereas the precise 
distribution and developmental changes of the 11β-HSD isoforms have as yet not been 
fully understood, including animals.  In the present study, the distribution of GRs and 
the identification of isoforms of 11β-HSD using immunostaining and polymerase chain 
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reaction (PCR) were investigated in adult and postnatal rat inner ear tissues.  Since it is 
already known that GRs in the cytoplasm are translocated to the nucleus by the 
stimulation of glucocortioids (Raddatz et al.,1996; Kawata, 2001) the present study 




2. Materials and Methods 
2.1. Experimental Animals 
Wister adult rats (8-10 weeks) and postnatal rats (day 1, 4, 10) were used in the 
present study.  Animal care and experimental procedures were performed in 
accordance with the Guidelines for Animal Experimentation of Nagasaki University 
with approval of the Institutional Animal Care and Use Committee.  All work was 
performed with approval from the Nagasaki University Institutional Animal Care and 
Use Committee (approval number 0802130651). 
 
2.2. Immunohistochemistry (paraffin section) 
2.2.1. Tissue preparation of rats 
Rats were deeply anesthetized by intraperitoneal injection of pentobarbital.  In 
adult rats, perfusion with 30 ml of ice-cold 4% paraformaldehyde (PFA) in phosphate 
buffered saline (PBS, pH7.4) via cardiac puncture was performed, and decapitation 
followed. However, cardiac perfusion was omitted in postnatal rats.  The dissection 
was carried out in ice cold Hank’s balanced saline solution (HBSS)(138mM NaCl, 
5mM KCl, 0.5mM MgCl2, 1.3mM CaCl2, 5mM glucose, pH 7.2) supplemented with 
10mM HEPES buffer.  The oval and round windows of the labyrinth were opened by 
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removal of the stapes footplate and the round window membrane, respectively.  In 
addition, the bony cap covering the apical turn of the cochlea was removed.  Samples 
were fixed with 4% PAF/PBS by gentle cochlear perfusion and by immersion of 4% 
PAF/PBS overnight at 4℃. Decalcification using 10% 
Ethylenediamine-N,N,N’,N’-tetraacetic acid, disodium salt, dehydrate (2Na(EDTA2Na) 
in PBS (pH 7.4) was performed for 10 days at 4℃.  The samples were then dehydrated 
through graded series of alcohols, cleared in xylene, and embedded in paraffin. 
 
2.2.2. Immunohistochemical labeling for GR, 11β-HSD1, and 11β-HSD2 
Sections, 4μm in thickness, were deparaffinized with toluene and rehydrated by 
serially graded ethanol solutions.  After being washed 3 times in PBS, the sections 
were autoclaved in 10mM citrate buffer for 10 min at 121℃.  Following the 
inactivation of endogenous peroxidase activity with 0.3% H2O2 in methanol for 15 min 
at room temperature, the sections were preincubated with 500μg/ml normal goat IgG 
and 5% bovine serum albumin (BSA) in PBS for 1 hour to block nonspecific reaction 
with the first antibody.  Polyclonal antibodies against GR (no.sc-1004, 
http://datasheets.scbt.com/sc-1004.pdf), 11β-HSD1 (no.sc-20175, 
http://datasheets.scbt.com/sc-20175.pdf) and 11β-HSD2 (no.sc-20176, 
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http://datasheets.scbt.com/sc-20176.pdf) were prepared by immunization of rabbits 
against synthetic peptides (Santa Cruz Biotechnology Inc, California, USA).  The 
antibodies showed a single band of the expected size in western blot analysis and the 
specificity was confirmed in previous other studies (Brewer JA, et al., 2002; Ge RS, et 
al., 2005; Honda, et al., 2008).  The sections were incubated with the first antibody of 
anti-GR (1:200), anti-11β-HSD1 (1:100), and anti-11β-HSD2 (1:100) with 5% BSA in 
PBS for overnight, washed 4 times with 0.075% Brij35 (B4184, Sigma-Aldrich, St. 
Louis, USA) in PBS.  Afterwards the sections were treated with CyTM3-conjugated 
Affinipure Goat anti-Rabbit IgG (H+L) (Jackson immuno research, USA, dilution 
1:200) for 1 hour.  After the sections were washed with 0.075% Brij35 in PBS, 
covered with Vectasheild mounting medium (Vector Laboratories, Inc.; California, 
USA) and observed in a confocal leaser microscope (LSM 510 META, Zeiss, Germany).  
Images were digitally captured and then analyzed using imaging software (Zen, Zeiss, 
Germany) provided and downloaded from Zeiss.  Control samples consisted of rat 
brain and kidney tissues known to contain GR, 11β-HSD1, or 11β-HSD2.  Technique 
controls were performed for each specimen using the same method with normal rabbit 
IgG but omitting the use of the primary antibody.  As positive controls for 11β-HSD2, 
the kidneys were stained using the same method with the primary antibody. 
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A double staining of GRs with 11β-HSD1 in the rat crista ampullaris was also 
performed to observe more precise distribution of GRs and 11β-HSD1.  For the double 
staining, Zenon Rabbit IgG Labeling kits Z25360 (Molecular Probes, USA) was used. 
 
2.3. reverse transcription – polymerase chain reaction (RT-PCR) 
2.3.1. Tissue preparation for RT-PC 
RT-PCR was further performed to confirm the presence of GRs and 11β-HSD 
isoforms in postnatal rats.  mRNA was isolated from 24 ears (4 rats at each postnatal 
stage of day 1, 4, and 10, respectively).  Rats were deeply anesthetized by 
intraperitoneal injection of pentbarbital (0.4mg/g body mass, Tokyo Chemical Industry, 
Tokyo, Japan) and diethyl ether, exsanguinated via the left ventricle with 70% 
ethanol/RNase-free water, and then decapitated.  The brain was removed from the 
skull, and the complete inner ear bony labyrinth capsules were dissected from the skull 
base.  The dissection was carried out in ice cold 10mM HEPES-buffered saline with 






2.3.2. Condition of RT-PCR 
     RNA was extracted using a RNease Mini Kit following the manufacture’s 
protocol (No.74104, Qiagen, Inc.;California,USA), and total RNA quality was 
determined with a Nanodrop ND-1000 Spectrophotomerter (Thermo Fisher Scientific, 
Inc.; Massachusetts, USA).  The extracted total RNA was further purified using DNase 
I Amplification Grade (no.18068-015, Invitrogen; California, US) in order to eliminate 
the DNA.  Total RNA obtained was reverse transcribed into complementary DNA 
(cDNA) by a standardized technique.  For reverse transcription, SuperScriptTMIII 
Reverse Transcriptase (no.18080-044, Invitrogen) was employed with random hexamer 
primers.  The cDNAs were synthesized using TaKaRa Ex Taq Hot Start Version 
(no.RR006A, Takara; Shiga, Japan).  The PCR reaction consisted of 4 min at 94℃, 
following by 35 cycles of 94℃ (30 sec), 55℃ (30 sec), 72℃ (30 sec), ending with 10 
min extension at 72℃.  All PCR products were run on 2% agarose gels and detected 
by etidium bromide.  cDNA fragments were then amplified using specific primers for 
rat GR, 11β-HSD1, and 11β-HSD2 (GeneBank accession No. NM_012576, 
NM_017080, NM_017081, respectively).  Primer sequences were as follows: rat GR 
(forward 5’-AAAATGGGTCGGTGCTTCTA-3’, reverse 




5’-TCCTGCCTCAACAACAAATC-3’), rat 11β-HSD2 (forward 
5’-CAAACCCTTCCCCCACAG-3’, reverse 5’-GCCACATCTCACGCTAAACTC-3’).  
Regarding the primer design, a previous PCR study was referenced (Pondugula et al., 
2006).  The expected lengths of the PCR products were 319, 303, and 301 bp, 
respectively.  As positive controls, brain was used for GRs and 11β-HSD1, and kidney 
was used for 11β-HSD2.   Water was used as a negative control.  
 
2.4. Translocation of GRs (Stria vascularis explants and cell counts) 
2.4.1. Condition of culture  
     Twenty cochleae were dissected from the cochleae of 10 rats (P4) rats and 
immediately placed in cold (4℃) 10mM HEPES-buffered saline with HBSS.  Twenty 
SV were removed from the cochleae and 10 explants put on a culture slide coated with 
20μl Cell Tek (Becton Dickinson Labware, USA) diluted 1:5 and covered with a 300μl 
culture medium consisting of Dulbecco’s Minimum Essential Medium (D-MEM ,No. 
12320, GIBCO, USA) (Contains 1,000 mg/L D-glucose, L-glutamine, 25mM HEPES 
buffer, pyridoxine HCl, and 110 mg/L sodium pyruvate.) with 0.1mg/ml dexamethasone 
(DMX), and 100units/ml penicillin.  The other 10 explants were put on a culture slid 
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with 300μl of the same culture medium without DMX.  All explants were kept in a 5% 
CO2 atmosphere at 37℃ for up to 3 hours.  Cells grown on the glass coverslips were 
fixed with 4%PFA/PBS for 20 min. 
 
2.4.2. Immunohistochemical labeling for GRs 
The cells were washed in PBS, permeabilized with 0.1% Triton X-100 in PBS for 
10 min.  Following the inactivation of endogenous peroxidase activity with 0.3% H2O2 
in methanol for 15 min at room temperature, specimens were incubated with the same 
antibody to GR used in the sections at a dilution of 1:200 in 5%BSA/PBS at 4°C 
overnight in a humidified chamber.  Specimens were then incubated with 
CyTM3-conjugated Affinipure Goat anti-Rabbit IgG (H+L) (Jackson immuno research, 
USA, dilution 1:200) for 1 hr, washed, and mounted. 
Then, immunostained specimens were analyzed with a confocal laser microscope 
(LSM 510 META, Zeiss,Germany).  Images were digitally captured and then analyzed 
using imaging software (Zen) provided and downloaded from Zeiss (Germany).  
Technique controls were performed for each specimen using the same method but 
omitting the use of the primary antibody.  Cells showing GRs in the nucleus were 
counted in an optic field of each explants and a ratio of the number of cells showing 
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GRs in the nucleus to cells showing GRs in the cytoplasm was calculated.  The 
investigator performing the cell counts was blinded with regard to the identity of the 
specimens until all counts were completed.  For SV cell counts, t-test was used for data 




3.1. Cellular localization of GRs, 11β-HSD1, and 11β-HSD2 in the adult rat 
cochlea (Figures 1A, B, C, D, and Table 1) 
3.1.1. GRs (Figures 1A) 
In midmodiolar cochlear cross-sections of matured rats, intense 
immunofluorescence labeling of GRs was observed in all cell types of the SV, the 
epithelial and mesothelial cells of Reissner’s membrane (RM), the SLig, the spiral 
limbus (SLib), the inner hair cells (IHCs) and the outer hair cells (OHCs), the cochlear 
nerve (CN), and the spiral ganglion cells (SGCs) (Figure 1A).  GRs were expressed 
mainly in the cytoplasm. 
 
3.1.2. 11β-HSD1 and 11β-HSD2 (Figure 1B, C, D and E) 
Intense immunofluorescence labeling of 11β-HSD1 was observed in the SV, the 
IHCs, and the OHCs.  The labeling in the SV was particularly intense in the marginal 
and basal cells, while it was weak in the intermediate cells (Figure 1B).  No 
immunofluorescence labeling of 11β-HSD2 was detected in any parts of the cochlea and 
in negative controls stained with normal rabbit IgG (Figure 1C and D).  The kidney 
collecting duct showed a positive immunostaining of 11β-HSD2 (Figure 1E). 
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3.2. Cellular localization of GRs, 11β-HSD-1, and 11β-HSD-2 in the adult rat 
crista ampullaris (Figures 2A to H, and Table 1) 
3.2.1. GRs (Figures 2A, B) 
Intense immunofluorescence labeling of GRs was observed in the vestibular hair 
cells (VHCs), the vestibular nerve (VN) fibers, and the dark cells (DCs) of the crista 
ampullaris in adult rats.  The immunofluorescence labeling of GRs was expressed in 
the cytoplasm.  
 
3.2.2. 11β-HSD1 and 11β-HSD2 (Figures 2C to F) 
Immunostaining of 11β-HSD1 was present in the apical side area of the VHCs and 
weakly expressed also in the apical side of DCs in adult (Figure 2C and D).   No 
immunofluorescence labeling was observed with the antibody of 11β-HSD2 (Figure 2E 
and F), and in negative controls stained with normal rabbit IgG (Figure 2G and H). 
 
3.3. Cellular localization and postnatal development of GRs, 11β-HSD1, and 
11β-HSD2 in the rat cochlea (Figures 3A-F, and Table 1). 
3.3.1. GR (Figures 3A to C)  
In the SV, intense immunofluorescence labeling of GRs was identified in all the 
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cells at all the postnatal days (P1, P4, and P10).  In the cells of the Kölliker's organ, the 
IHCs, the OHCs, and the CN, it can be seen at P1 (Figure 3A).  These findings did not 
change through all the postnatal developmental periods observed in the present study 
(Figure 3A, -B, and -C).  In the supporting cells, it seemed to be positive at P1, but was 
not observed at P10. 
 
3.3.2. 11β-HSD1, and 11β-HSD2 (Figures 3D to F) 
At P1 (Figure 3D), moderate immunofluorescence labeling of 11β-HSD1 was 
observed in the cells of Kolliker's organ, the IHCs, and the OHCs.  In the SV, the 
labeling was weak at P1 and P4 (Figure 3D and E), but it was clearly identified in the 
marginal cells and the basal cells at P10 (Figure 3F).  It seemed weak in the 
intermediate cells at P10.  Immunoreactivity of 11β-HSD2 was not detected in any 
area of the cochlea at any postnatal day (Data not shown).  
 
3.4. Cellular localization and postnatal development of GRs, 11β-HSD-1, and 
11β-HSD-2 in the crista ampullaris (Figures 4A, 4B, and Table 1) 
3.4.1. GRs (Figures 4A-1 to A-6, and 4B1-2) 
Intense immunofluorescence labeling of GRs was observed in the VHCs, the DCs, 
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and the VN of the crista ampullaris at all the postnatal days (P1, P4, and P10) (Figure 
4A-1, - 2, -3, -4, -5, and 6).  It was clearly expressed in the cytoplasm of the type I and 
typeⅡ sensory cells of the crista ampullaris (Figure 4B-1,and 2).  
 
3.4.2. 11β-HSD1 and 11β-HSD2 (Figures 4A-7 to A-12, and 4B1-2) 
At all postnatal days, 11β-HSD1 was present in the apical side of the VHCs, while 
in the DCs, it was expressed very weakly.  Immunofluorescence labeling of 11β-HSD2 
was not observed in any area of the crista ampullaris (Data not shown).  In a double 
staining with GRs and 11β-HSD1, GRs were clearly observed in the cytoplasm of the 
VHCs and 11β-HSD1 was observed in the cytoplasm in the apical area of the VHCs 
(Figure 4B-1,and 2). 
 
3.5. RT-PCR analysis of GRs, 11β-HSD1, and 11β-HSD2 mRNAs (Figure 5) 
RT-PCR products derived from mRNA of GRs, 11β-HSD1, and 11β-HSD2 were 
detected as single bands located in the expected size on agarose gel in the OC, the 
vestibular organ, and the SV.  mRNAs of GRs, 11β-HSD1, and 11β-HSD2 were 
present already at P1, and this presence was observed in developmental days P1, P4, 
and P10.  RT-PCR products derived from the mRNAs were detected in positive 
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control samples obtained from the brain and the kidney. 
 
3.6. Cellular localization of GRs in the stria vascularis in culture (Figures 6A, B, 
and Table 2) 
In the medium without DXM, GRs were identified in the cytoplasm of all cells of 
the SV (Figure 6A).  In the medium containing of DXM, some cells showed GRs in 
the cytoplasm, however, the number of cells showing GRs in the nucleus was higher 
(Figure 6B).  In the medium containing DXM, the number of cells showing GRs in the 
nucleus was 7.03±8.16 (mean±SD)%, and in the medium without DXM the number 
was 0% (Table 2).  The number of cells showing GRs in the nucleus significantly was 




In the present study, precise cellular localization of GRs and distribution of 
11β-HSD isoforms were identified in the rat inner ear tissue, indicating that steroid 
regulation by GRs and 11β-HSD isoforms is present in the inner ear.  This further 
indicates that a lot of site and structures may be targets for steroids, accounting for the 
clinical efficacy of steroids on various inner ear diseases.   In particular, it should be 
noted that mRNA and intense immunofluorescent labeling of GRs were observed in the 
SV of the postnatal and adult rats; this had not been clearly indicated in previous studies 
(Ten et al., 1993; Zuo et al., 1995).  Low expression of GRs in the SV in postnatal rats 
was explained as a coincidence with developmental changes of endocochlear potential 
(EP) (Zuo et al., 1995).  The difference between our results and theirs is assumed to be 
due to differences in sensitivity in the respective experimental procedures.  
In general, Na+,K+-ATPase is assumed to be regulated by the mineralcorticoid 
receptors (MR) and also in the inner ear, Na+,K+-ATPase is regulated by MR (Pitovski, 
et al., 1993).   However, GRs also participate in the regulation of Na+,K+-ATPase 
(Hatou, et al., 2009; Derfoul. et al., 1998).  Studies in rat have shown a positive 
correlation between serum levels of corticosteroid (glucocorticoid and 
mineralocorticoid) hormones and the amount of Na+,K+-ATPase in the inner ear (Curtis 
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et al., 1993; Rarey et al., 1989).   Low levels of GRs in immunostaining and ELISA 
were observed in the previously studies in the SV (Rarey and Curtis, 1996; Zuo et al., 
1995).  In the rat SV, Na+,K+-ATPase is highly expressed, and that such low levels of 
GRs do not coincide with the high expression of Na+,K+-ATPase (Erichsen et al., 1998).  
Our results regarding GRs in the SV coincide with the high expression of 
Na+,K+-ATPase.  Although it is known that the absence of adrenal hormones does not 
affect the gross cochlear potentials (endocochlear potential:EP) (Lohuis et al., 1990), 
depletion of endogenous glucocorticoids by bilateral adrenalectomy in rats was reported 
to cause a decrease in the volume of the marginal cells leading to shrinkage of the scala 
media (Lohuis et al., 2000).  Thus, regulation of fluid homeostasis by the SV is 
assumed to be highly dependent on circulating glucocorticoids.  Furthermore, the 
strong GRs expression seen in the SV at the early developmental stages in this study is 
assumed to be required for maintaining fluid homeostasis and further maturation as well 
as EP formation. 
In general, activity of glucocorticoids is classically explained by genomic 
mechanisms involving binding to a cytosolic receptor and stimulation (trans-activation) 
or inhibition (trans-repression) of a target gene transcription.  Currently, it is widely 
accepted that in absence of the ligand, the receptors are part of a large protein 
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heterocomplex containing a number of chaperone proteins stabilizing the complex in the 
cytoplasm (Sarabdjitsingha RA, 2009).  GRs bound to glucocorticoids are present in 
the nucleus, while those not bound are present in the cytoplasm.  In the previous 
immunohistochemical studies of GRs in the inner ear, immunolabeling of GRs was 
observed in the cytoplasm but not in the nucleus.  Also in the present study, 
immunostaining of GRs was observed in the cytoplasm in nearly all sections.  To 
investigate whether subcellular localization of GRs in the SV changes as a consequence 
of corticosteroid treatment, a short time culture of the SV with a high dose of DXM was 
performed.  In the medium without DXM, almost all of GRs was located in the 
cytoplasm.  However, in the medium containing DXM, GRs were translocated to the 
nucleus.  This indicates that what we observed in the sections of the SV are GRs not 
bound to glucocorticoids in the cytoplasm and also that GRs present in the cytoplasm 
are translocated to the nucleus by stimulation of glucocorticoid.  According to a classic 
model, the free molecules of glucocorticoids enter the target cell by passive diffusion 
through the plasma membrane and form a ligand–receptor complex.  Subsequent 
activation or repression of the target gene reflects the selective effect of a given 
glucocorticoids.  This genomic process is normally slow, i.e. it takes hours before the 
outcome of the hormonal signaling manifests itself.  Recent studies suggest that 
20 
 
glucocorticoids use receptors on the plasma membranes and / or cytoplasm both to gain 
access to the intracellular compartment and to modulate cellular functions through 
non-genomic mechanisms (Moore et al., 1995; Falkenstein et al., 2000; Johnson et al., 
2005; Hu et al., 2008).  The presence of non-genomic regulation of potassium ion 
recycling is known to occur in the SV (Lee and Marcus, 2002), and therefore, a part of 
GRs present in the cytoplasm may be required for the non-genomic rapid action such as 
potassium ion recycling and GRs translocated may show the genomic action.  GRs 
expression was observed also in the cochlear hair cells, the supporting cells, and RM.  
Glucocorticoids protect the cochlear hair cells against cytotoxicity (Tahera Y, et al., 
2006; Haake SM, et al., 2009) or pathological states such as noise trauma (Tahera Y, et 
al., 2007; Meltser I, et al., 2009).  The supporting cells are known to be related to hair 
cell regeneration (Löwenheim H, et al., 1999) and ion regulation (Mistrik and Ashmore, 
2009).  In the RM of mice, PCR and electrophysiological methods have indicated that 
Na+ absorption is mediated by apical epithelial sodium channel (ENaC) and/or other 
amiloride-sensitive channels, basolateral Na+ - K+ ATPase, and K+ -permeable channels 
under the control of glucocorticoids (Kim et al., 2009).  GRs possibly participate in the 
regulation of cell cycle, gene, ion, and fluid transport in the rat cochlea. 
There has also been some controversy regarding the presence of GRs in the 
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peripheral vestibular organs.  In the BALB mice, a report suggested that the 
immunoreactivity of GRs was hardly distinguishable, and that the VHCs were not likely 
to be direct targets of glucocorticoid (Shimazaki et al., 2002).  However, functional 
regulation by glucocorticoids in the peripheral vestibular system has already been 
proven.  For instance, corticosteroids are known to have a protective effect also in the 
vestibular maculae (Pondugula et al., 2004) and to regulate ions such as ENaC in animal 
experiments of the semicircular canal duct epithelium (Pondugula et al., 2006; Taura et 
al., 2006).  In the present study, immunoreactivity of GRs was observed in the 
cytoplasm of the VHCs, the DCs, and the VN.  This result implies that these tissues are 
likely to be targets of glucocorticoids, and that their function may be under control of 
genomic and non-genomic effects of glucocorticoids. 
Although SV and DCs were found to contain GRs in this study, in a previous study, 
11β-HSD was found in SLig but not found in the SV and the DCs by immunoblotting 
and immunocytochemistry by use of an antibody generated against rat liver 11β-HSD 
(Ten et al., 1994).  However, so far no study has dealt with the precise distribution of 
11β-HSD isoforms in the cochlea and the vestibular organs.  In the present study, 
11β-HSD1 was found in a lot of sites in the cochlea and vestibule, as well as in the CN 
and the VN in the adult rat.  In a study that dealt with postnatal rats (Ten et al., 1997), 
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a) 11β-HSD was not found in the cochlea of rats at birth, b) the expression appeared at 
low levels at the 12th postnatal day in the SLig, and c) adult-like higher levels of 
expression were observed from the 15th postnatal day on.  These findings may account 
for the EP changes during development.  In our study, although both expression of 
mRNA and immunoreactivity of 11β-HSD1 increased during development, the 
expression of 11β-HSD1 as well as GRs was found even at postnatal day 1.  Although 
the discrepancy between our results and the previous study is assumed to be based on 
the difference of technical application, the expression of GRs and 11β-HSD isoforms at 
early developmental stages implies that the isoforms also participate in the maturation 
and maintenance of the homeostasis of the cochlea with GRs.  Especially, 11β-HSD1 
is suggested to start controlling the cellular concentration of glucocorticoids in the hair 
cells at the early developmental stages.  Localization of 11β-HSD1 does not 
completely overlap with that of GRs in the inner ear, which is observed in other organs.  
11β-HSD1 is not always expressed in the site where GRs are present in other organs, 
the concentration of gluococorticoids in the target cells is regulated by other enzyme as 
well as 11β-HSD1 (Oppermann et al., 1997; Seckl, 2004; Draper and Stewart, 2005). 
11β-HSD2 was not observed in any site in the inner ear in the present study.  In 
the previous PCR study (Pondugula et al., 2006), a quantitative PCR indicated that 
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11β-HSD1 was the predominant enzyme in the semicircular canal duct epithelium.  In 
addition, it was also indicated that mRNA of 11β-HSD2 expression was comparatively 
small and was not affected by dexamethasone (Pondugula et al., 2006).  In the present 
study, compared with11β-HSD2, immunostaining of 11β-HSD1 in the crista ampullaris 
was predominant; this was compatible with the quantitative PCR study.  Since in 
11β-HSD2the kidney used as the positive control was clearly stained, a failure of 
immunostaining of 11β-HSD2 in the inner ear tissues is not assumed to be due to a 
technical error.  In the organ of Corti, expression of GRs mRNA or molecules related 
to stress is modulated by stress or sound condition (Terunuma, et al., 2001; Meltser, et 
al., 2009; Mazurek, et al., 2010).  11β-HSD1 is assumed to be the main isoform of 
11β-HSD in the inner ear, however, 11β-HSD2 levels may have been too low as to be 
detected by immunostaining, or expressed under a special condition of intracellular 
glucocorticoid concentration.  11β-HSD1 is known to participate in the control of 
intraocular pressure and cerebrospinal fluid production, and therefore, 11β-HSD1 is 
likely to participate in controlling fluid homeostasis in the inner ear.  In the present 
study, 11β-HSD1 is shown to be in the cytoplasm in the apical area of the cochlear and 
vestibular hair cells as well as in the SV.  Since 11β-HSD1 converts inactive-form 
cortisone to active-form cortisol, it is suggested that 11β-HSD1 controls cellular 
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function of the inner ear at receptor and prereceptor levels, especially playing an 
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>We investigated the distribution of GRs and 11β-HSD isoforms in the rat inner ear. 
>GRs and 11β-HSD1 were present in most cells in the rat inner ear tissues. 
>Immunostaining of 11β-HSD2 was not observed in any of the inner ear tissues. >Local 
steroid regulation by GRs and 11β-HSD is present in the inner ear. 
Table 1.  Localization of GR and 11β-HSD1 in rat inner ear tissues. 
P1 = the postnatal day 1, P4 = the postnatal days 4, P10 = the postnatal days 10,GR = 
glucocorticoid receptors, 11β-HSD1 = 11β-hydroxysteroid dehydrogenase type 1, IHC = 
the inner hair cell, OHC = the outer hair cell, SLib = the spiral limbus, SLig = the spiral 
ligament, RM = Reissner’s membrane, SV = the stria vascularis, SGC = the spiral 
ganglion cell, CN = the cochlear nerve, VHC = the vestibular hair cell, DC = the dark 
cell, VN = the vestibular nerve, ＋＋＋ = intense staining, ＋＋ = moderate staining, 
＋ = slight staining, － = negative 
 
   Adult Development 
P1 P4 P10 
GR Cochlea IHC ＋＋＋ ＋＋＋ ＋＋＋ ＋＋＋ 
OHC ＋＋ ＋＋ ＋＋ ＋＋ 
SLib ＋ － － － 
SLig ＋＋ － － ＋ 
RM ＋＋＋ ＋＋ ＋ ＋ 
SV ＋＋＋ ＋＋＋ ＋＋＋ ＋＋＋ 
SGC ＋ － － － 
CN ＋＋＋ ＋＋ ＋＋ ＋＋ 
Vestibule VHC ＋＋＋ ＋＋＋ ＋＋＋ ＋＋＋ 
DC ＋＋＋ ＋＋＋ ＋＋＋ ＋＋＋ 
VN ＋＋＋ ＋＋＋ ＋＋＋ ＋＋＋ 
11β-HSD1 Cochlea IHC ＋＋＋ ＋＋＋ ＋＋ ＋＋ 
OHC ＋＋＋ ＋＋＋ ＋＋ ＋＋ 
SLib － － － － 
SLig － － － － 
RM ＋ ＋ ＋ ＋ 
SV ＋＋＋ ＋ ＋ ＋＋＋ 
SGC － － － － 
CN － － － － 
Vestibule VHC ＋＋＋ ＋＋＋ ＋＋＋ ＋＋＋ 
DC ＋ ＋ ＋ ＋ 
VN － － － － 
Table 2.  Counts of cells showing translocation of GRs 
 
 DXM (-) DXM (+) 
N/AC (%) 0 7.03±8.16* 
N/AC (%) = Ratio of the number of cells showing GRs in the nucleus to that of all cells 
in each observed area.  DMX (-) = culture in the absence of dexamethasone, DXM (+) 
= culture in the presence of dexamethasone.  Data are shown as mean±SD.  * = 
p<0.05. 
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